Geode Capital Management, LLC Satsuma Pharmaceuticals, Inc. Transaction History

Geode Capital Management, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$0.7 - $1.07 $3,665 - $5,602	5,236 Added 1.28%	414,344 $290,000
Q4 2022 Feb 13, 2023	BUY	$0.61 - $5.06 $132,774 - $1.1 Million	217,663 Added 113.69%	409,108 $368,000
Q3 2022 Nov 14, 2022	BUY	$4.19 - $7.95 $111,902 - $212,320	26,707 Added 16.21%	191,445 $1.15 Million
Q2 2022 Aug 12, 2022	BUY	$2.59 - $4.3 $151,173 - $250,982	58,368 Added 54.87%	164,738 $682,000
Q1 2022 May 13, 2022	BUY	$3.78 - $5.32 $3,341 - $4,702	884 Added 0.84%	106,370 $404,000
Q4 2021 Feb 11, 2022	BUY	$4.15 - $6.24 $27,734 - $41,701	6,683 Added 6.76%	105,486 $474,000
Q3 2021 Nov 12, 2021	BUY	$4.54 - $7.17 $115,329 - $182,139	25,403 Added 34.61%	98,803 $460,000
Q2 2021 Aug 13, 2021	SELL	$4.8 - $7.25 $221,553 - $334,638	-46,157 Reduced 38.61%	73,400 $517,000
Q1 2021 May 12, 2021	BUY	$4.57 - $7.18 $87,753 - $137,870	19,202 Added 19.13%	119,557 $706,000
Q4 2020 Feb 12, 2021	SELL	$3.56 - $5.09 $49,743 - $71,122	-13,973 Reduced 12.22%	100,355 $462,000
Q3 2020 Nov 13, 2020	SELL	$3.85 - $28.47 $5,289 - $39,117	-1,374 Reduced 1.19%	114,328 $444,000
Q2 2020 Aug 13, 2020	BUY	$16.01 - $34.69 $541,298 - $1.17 Million	33,810 Added 41.29%	115,702 $3.33 Million
Q1 2020 May 14, 2020	BUY	$14.53 - $30.69 $252,662 - $533,668	17,389 Added 26.96%	81,892 $1.76 Million
Q4 2019 Feb 13, 2020	BUY	$9.32 - $19.68 $601,167 - $1.27 Million	64,503 New	64,503 $1.27 Million

Ticker STSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,587,500
Description
Satsuma Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, developing novel therapeutic products for the acute treatment of migraines. The company's lead product candidate is STS101, a drug-device combination of a proprietary dry-powder formulation of dihydroergotamine mesylate, which is in SUMMIT Phase 3 efficacy trials and can ...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.